The chloroethylnitrosoureas: Sensitivity and resistance to cancer chemotherapy at the molecular level

Cancer Investigation

Volumn 15, Issue 6, 1997, Pages 588-598

  Ludlum, David B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; CARMUSTINE; CHLORMETHINE; CHLOROETHYLNITROSOUREA DERIVATIVE; CHLOROZOTOCIN; CYTOSINE; DNA; GUANINE; LOMUSTINE; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA; NIMUSTINE; SEMUSTINE; STREPTOZOCIN;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CROSS LINKING; DNA ADDUCT; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; HYDROPHOBICITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031469549     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709047601     Document Type: Review

References (68)

1. Goodman LS, Wintrobe MM, Dameshek W, et al: Nitrogen mustard therapy. J Am Med Assoc 132:126-132, 1946.
2. Hemminki K, Ludlum DB: Covalent modification of DNA by antineoplastic agents. J Natl Cancer Inst 73: 1021-1028, 1984.
3. Greene MO, Greenberg J: The activity of nitrosoguanidines against ascites tumors in mice. Cancer Res 44:1166-1171, 1960.
4. Schepartz SA: Early history and development of the nitrosoureas. Cancer Treat Rep 60:647-649, 1976.
5. Skipper HE, Schabel FM Jr, Trader MW, et al: Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy. Cancer Res 21:1154-1164, 1961.
6. Montgomery JA: Chemistry and structure-activity studies of the nitrosoureas. Cancer Treat Rep 60:651-664, 1976.
7. Montgomery JA: The development of the nitrosoureas: A study in congener synthesis. In: Nitrosoureas: Current Status and New Developments, edited by AW Prestayko, ST Crooke, et al, New York, Academic Press, 1981, pp 3-8.
8. Goldin A: Historical overview of nitrosourea development. In: Nitrosoureas in Cancer Treatment, edited by B Serrou, PS Schein, J-L Imbach, Amsterdam, Elsevier, 1981, pp 3-11.
9. Evans JS, Gerritsen GC, Mann KM, et al: Antitumor and hyperglycemic activity of streptozotocin (NSC-27914) and its cofactor, U-15, 774. Cancer Chemother 48:1-6, 1965.
10. Johnston TP, McCaleb GS, Montgomery JA: Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin. J Med Chem 18:104-106, 1975.
11. Hoth DF, Duque-Hammershaimb L: Chlorozotocin: Clinical trials. In: Nitrosoureas: Current Status and New Developments, edited by AW Prestayko, ST Crooke, LH Baker, SK Carter, PS Schein, New York, Academic Press, 1981, pp 387-398.
12. Shimizu F, Arakawa M: Antitumor activity of 3-{(4-amino-2-methyl-5-pyrimidinyl) methyl}-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors. Gann 69:545-548, 1978.
13. Carter SK, Schabel FM Jr, Broder LE, et al: 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) and other nitrosoureas in cancer treatment: A review. Adv Cancer Res 16:273-332, 1972.
14. Colvin M: Alkylating agents and platinum antitumor compounds. In: Cancer Medicine, 3rd ed, edited by JF Holland, E Frei III, RC Bast Jr, DW Kufe, DL Morton, RR Weichselbaum, Philadelphia, Lea & Febiger, 1993, pp 733-754.
15. Wheeler GP: Mechanism of action of nitrosoureas. In: Handbook of Experimental Pharmacology, Vol XXXVII/2, edited by AC Sartorelli, DG Johns, New York, Springer-Verlag, 1975, pp 65-84.
16. Lijinsky W, Garcia H, Keefer L, et al: Carcinogenesis and alkylation of rat liver nucleic acids by nitrosomethylurea and nitrosoethylurea administered by intraportal injection. Cancer Res 32:893-897, 1972.
17. Kramer BS, Fenselau CC, Ludlum DB: Reaction of BCNU (1,3-bis[2-chloroethyl]-1-nitrosourea) with polycytidylic acid. Substitution of the cytosine ring. Biochem Biophys Res Commun 56:783-778, 1974.
18. Ludlum DB, Kramer BS, Wang J, et al: Reaction of 1,3-bis-(2-chloroethyl)-1-nitrosourea with synthetic polynucleotides. Biochemistry 14:5480-5485, 1975.
19. Ludlum DB, Tong WP: DNA modification by the nitrosoureas: Chemical nature and cellular repair. In: Experimental and Clinical Progress in Cancer Chemotherapy, edited by FM Muggia, Boston, M Nijhoff, 1985, pp 141-154.
20. Ludlum DB: DNA alkylation by the haloethylnitrosoureas: Nature of modifications produced and their enzymatic repair or removal. Mutat Res 233:117-126, 1990.
21. Singer B, Grunberger D: Molecular Biology of Mutagens and Carcinogens. New York, Plenum Press, 1983, pp 56-69.
22. Gombar CT, Tong WP, Ludlum DB: Mechanism of action of the nitrosoureas. IV. Reactions of BCNU and CCNU with DNA. Biochem Pharmacol 29:2639-2654, 1980.
23. Tong WP, Kirk MC, Ludlum DB: Molecular pharmacology of the haloethyl nitrosoureas: Formation of 6-hydroxyethylguanine in DNA by reaction with BCNU (N,N′-bis-[2-chloroethyl]-N-nitrosourea). Biochem Biophys Res Commun 100:351-357, 1981.
24. 6-(2-chloroethyl)guanine: A putative intermediate in the cytotoxic reaction of chloroethylnitrosoureas with DNA. Biochem Biophys Res Commun 148:1124-1128, 1987.
25. Tong WP, Ludlum DB: Mechanism of action of the nitrosoureas. III. Reaction of bis-chloroethyl nitrosourea and bis-fluoroethyl nitrosourea with adenosine. Biochem Pharmacol 28:1175-1179, 1979.
26. 2,3-ethanoguanine in DNA after in vitro treatment with the therapeutic agent, N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea. Carcinogenesis 11:223-228, 1990.
27. Kohn KW: Interstrand cross-linking of DNA by 1,3-bis-(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res 37:1450-1454, 1977.
28. Tong WP, Ludlum DB: Formation of the cross-linked base, diguanylethane, in DNA treated with N,N′-bis(2-chloroethyl)-N-nitrosourea. Cancer Res 41:380-382, 1981.
29. 1-deoxyguanosinyl]-ethane, in DNA treated with N,N′-bis(2-chloroethyl)-N-nitrosourea (BCNU). Cancer Res 42:3102-3105, 1982.
30. Erickson LC, Laurent G, Sharkey NA, et al: DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature 288:727-729, 1980.
31. 6-alkylguanine-DNA alkyltransferasae complexed with BCNU-treated, synthetic oligonucleotide. Nucleic Acids Res 17:6581-6590, 1989.
32. MacFarland JG, Kirk MC, Ludlum DB: Mechanism of action of the nitrosourea, VI. Synthesis of the 2-haloethylnitrosourea-induced DNA crosslink, 1-(3-cytosinyl),2-(1-guanyl)ethane. Biochem Pharmacol 39:33-36, 1990.
33. 1-(2′-deoxyguanosinyl)] ethane in DNA reacted with 1-(2-chloroethyl)-1-introsourea. Chem Res Toxicol 6:434-438, 1993.
34. Ali-Osman F: Quenching of DNA crosslink precursors of chloroethylnitrosoureas and attenuation of DNA interstrand crosslinking by glutathione. Cancer Res 49:5258-5261, 1989.
35. Bodell WJ, Tokuda K, Ludlum DB: Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-N-nitrosourea. Cancer Res 48:4489-4492, 1988.
36. 6-methylguanine-DNA methyltransferase. Nucleic Acids Res 11:7743-7758, 1983.
37. Brent TP: Suppression of crosslink formation in chloroethylnitrosourea-treated DNA by an activity in extracts of human leukemic lymphoblasts. Cancer Res 44:1887-1892, 1984.
38. 6-alkylguanine-DNA alkyltransferase. Cancer Res 46:3353-3357, 1986.
39. Benett RA, Pegg AE: Alkylation of DNA in rat tissues following adminstration of streptozotocin. Cancer Res 41:2786-2790, 1981.
40. 6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acids Res Mol Bio 51:167-223, 1995.
41. Karran P: Possible depletion of a DNA repair enzyme in human lymphoma cells by subversive repair. Proc Natl Acad Sci USA 82:5285-5289, 1985.
42. 6-alkylguanines. Cancer Res 45:6413-6417, 1985.
43. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87:5368-5372, 1990.
44. Futscher BW, Micetich KC, Barnes DM, et al: Inhibition of a specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells. Cancer Commun 1:65-73, 1989.
45. 6-alkylguanine-DNA alkyltransferase by streptozotoc in in vivo. Cancer Res 49:3134-3138, 1989.
46. Allay JA, Dumenco LL, Koc ON, et al: Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85:3342-3351, 1995.
47. Moritz T, Mackay W, Glassner BJ, et al: Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res 55:2608-2614, 1995.
48. Belanich M, Pastor M, Randall T, et al: Retrospect study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res 56:783-788, 1996.
49. 6-Alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(chloroethyl)-1-nitrosourea in four medulloblastoma cell lines. Oncol Res 4:241-248, 1992.
50. 6-Alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines. Br J Cancer 66:840-843, 1992.
51. Kacinski BM, Rupp WD, Ludlum DB: Repair of haloethylnitrosourea-induced DNA damage in mutant and adapted bacteria. Cancer Res 45:6471-6474, 1985.
52. 6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents. Cancer Res 52:32-35, 1992.
53. Hata H, Numata M, Tohda H, et al: Isolation of two chloroethyl-nitrosourea-sensitive Chinese hamster lines. Cancer Res 51:195-198, 1991.
54. Lindahl T, Sedgwick B, Sekiguchi M, et al: Regulation and expression of the adaptive response to alkylating agents. Annu Rev Biochem 57:133-157, 1988.
55. 2,3-ethanoguanine from haloethylnitrosourea-treated DNA by Escherichia coli 3-methyladenine DNA glycosylase II. Carcinogenesis 12:1971-1973, 1991.
56. Habraken Y, Carter CA, Kirk MC, et al: Release of 7-alkylguanines from N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea-modified DNA by 3-methyladenine DNA glycosylase. Cancer Res 51:499-503, 1991.
57. Matijasevic Z, Bodell WJ, Ludlum DB: 3-Methyladenine DNA glycosylase activity in a glial cell line sensitive to the haloethylnitrosoureas in comparison with a resistant cell line. Cancer Res 51:1568-1570, 1991.
58. Cappelli E, Redaelli A, Rivano ME, et al: Repair of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea-induced damage by mammalian cell extracts. Carcinogenesis 16:2267-2270, 1995.
59. Engelward B, Dreslin A, Christensen J, et al: Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and killing. EMBO J 15:945-952, 1996.
60. Parker S, Kirk, MC, Ludlum DB, et al: Reaction of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) wtih guanosine: Evidence for a new mechansim of DNA modification. Biochem Biophys Res Commun 139:31-36, 1986.
61. Naghipur A, Ikonomou MG, Kebarle P, et al: Mechanism of action of (2-haloethyl)nitrosoureas on DNA: Discrimination between alternative pathways of DNA base modification by 1,3-bis-(2-fluoroethyl)-1-nitrosourea by using specific deuterium labeling and identification of reaction products by HPLC/tandem mass spectrometry. J Am Chem Soc 112:3178-3187, 1990.
62. Tong WP, Kohn KW, Ludlum DB: Modifications of DNA by different haloethylnitrosoureas. Cancer Res 42:4460-4464, 1982.
63. Hartley JA, Gibson NW, Kohn KW, et al: DNA sequence specificity of guanine-N7 alkylation by three antitumor chloroethylating agents. Cancer Res 46:1943-1947, 1986.
64. 32P-end-labelled DNA of N-alkyl-N-nitrosoureas linked to minor groove binding lexitropsins. IARC Sci Publ 105:439-442, 1991.
65. Chen FX, Zhang Y, Church KM, et al: DNA crosslinking, sister chromatid exchange and cytotoxicity of N-2-chloroethylnitrosoureas tethered to minor groove binding peptides. Carcinogenesis 14:935-940, 1993.
66. Kann HE Jr: Carbamoylating activity of the nitrosoureas. In: Nitrosoureas: Current Status and New Developments, edited by AW Prestayko, ST Crooke, LH Baker, SK Carter, PS Schein, New York, Academic Press, 1981, pp 95-105.
67. 6-alkylguanine-DNA alkyltransferase. J Med Chem 35:4486-4491, 1992.
68. 6-alkylguanine-DNA alkyltransferase. J Med Chem 37:342-347, 1994.